Neuraly Case Study: Helping a revolutionary clinical-stage biotechnology company become GCP compliant
With two clinical studies in Phase II and three more in pre-clinical stages, Neuraly – a clinical-stage biotechnology company – sought to outsource the archival of the electronic trial master file (eTMF) to ensure that they were compliant with the requirements that have been set out by Good Clinical Practice (GCP).
- Safeguarding the data to ensure that it is not lost or corrupted.
- Archiving the data in such a way that it could be easily found if required.
- Preserving the data so that the information could be read and used.
As part of the implementation and integration of the archiving and preservation solution, Neuraly and Arkivum identified and defined all of their requirements ensuring they were fully compliant with FDA regulations, GCP standards and in alignment with ALCOA+ principles.
If you’re interested in reading more about Neuraly’s digital preservation journey and how they became compliant with these regulations, please click here.
18 Feb, 2021
New eBook: An eTMF Archiving and Preservation Guide
According to our research less than one third of sponsors think that they are archiving their eTMF in adherence to archiving regulations. The complex regulatory landscape has…
01 Dec, 2020
Managing your eTMF archive: an effective approach to digital preservation
Last year we published a post on good electronic Trial Master File (or eTMF) archiving practices and what you needed to know. Given the time that’s passed,…
03 Mar, 2021
When is the right time to archive your eTMF?
The archival of eTMFs has been the focus of much discussion since regulators began to increase their focus on the topic. Both the US Food and Drug…